Vaping vs Smoking: 2026 Long-Term Health Comparison
Bottom line: If you're a current smoker weighing vaping as an alternative, the evidence is clear: vaping is substantially less harmful than smoking combustible cigarettes. Public Health England's landmark finding that vaping is approximately 95% less harmful than smoking remains the consensus position of major public health bodies including the UK National Health Service and the Royal College of Physicians. But "less harmful" does not mean "harmless." This guide breaks down the evidence across six health dimensions — cancer, cardiovascular, respiratory, reproductive, immune, and mental health — with confidence levels on every claim. If you've just switched from disposables to a refillable system using our transition guide, this is the science behind why that switch matters.
PHE Harm Reduction
Carcinogens in Aerosol
Cochrane Cessation
Why This Comparison Matters in October 2026
October 2026 is a pivotal moment for the vaping-vs-smoking debate. The FDA's accelerated PMTA review process — covered in our regulation analysis — is producing a growing list of authorized products that have passed rigorous safety review. Meanwhile, the enforcement crackdown on illicit disposables, documented in our Schumer FDA probe report, is pushing the market toward regulated products. For the first time, American consumers can choose between cigarettes and a growing selection of FDA-authorized vape products.
This matters because the core question — "is vaping actually better than smoking?" — has been muddied by a decade of conflicting headlines. The EVALI outbreak of 2019, caused by illicit THC cartridges cut with vitamin E acetate, damaged public perception of all vaping products. This guide separates the evidence from the noise.
The Combustion Difference: Why Vaping Fundamentally Differs
Understanding the vaping-vs-smoking comparison starts with one word: combustion.
When a cigarette is lit, tobacco burns at 600-900°C (1,100-1,650°F). This combustion produces:
- Tar: A sticky mixture of hundreds of chemicals that deposits in the lungs, causing cancer, COPD, and emphysema
- Carbon monoxide (CO): A poisonous gas that binds to hemoglobin, reducing oxygen delivery to organs
- 7,000+ chemical compounds: Including 70+ known or probable carcinogens (benzene, formaldehyde, nitrosamines, polonium-210)
- Particulate matter: Microscopic particles that penetrate deep into lung tissue
Vaping devices heat e-liquid at 150-300°C (300-570°F) — well below combustion temperature. No tobacco burns. No tar forms. No carbon monoxide is produced. The aerosol contains:
- Nicotine (in most e-liquids)
- Propylene glycol (PG) and/or vegetable glycerin (VG) — the base liquids
- Flavoring compounds (food-grade, but inhalation safety is still being studied)
- Trace levels of some compounds also found in smoke (formaldehyde, acrolein) — but at levels 90-99% lower
The key insight: The danger of smoking comes primarily from combustion products, not from nicotine. Vaping eliminates combustion. This single fact is the foundation of the PHE 95% finding. For more on what's actually in vape aerosol, see our e-liquid ingredients science guide.
Six Health Dimensions: Head-to-Head Evidence
1. Cancer Risk
| Metric | Smoking | Vaping | Reduction |
|---|---|---|---|
| IARC-listed carcinogens | 70+ compounds | 9 compounds (trace levels) | ~87% reduction |
| Tar exposure | Yes — primary carcinogen delivery | None — no combustion | 100% elimination |
| Formaldehyde exposure | High (from combustion) | Low (from PG thermal decomposition at high temps) | 90-99% reduction |
| Nitrosamines (TSNAs) | High (tobacco-specific) | Trace (only in tobacco-derived nicotine) | 97-99% reduction |
| Polycyclic aromatic hydrocarbons | High (from combustion) | None | 100% elimination |
Evidence Confidence: Cancer Risk
HIGH Smoking causes cancer — established beyond doubt with millions of cases and decades of epidemiological data.
MODERATE Vaping significantly reduces carcinogen exposure — chemical analysis confirms 87-99% reduction in known carcinogens. However, long-term cancer risk from vaping cannot be fully assessed because vaping has not existed long enough for epidemiological cancer studies (which require 20-30 year latency periods).
Key uncertainty: Whether decades-long inhalation of low-level formaldehyde and flavoring compounds in vape aerosol increases cancer risk above baseline. No confirmed cases of cancer caused solely by vaping exist as of 2026.
2. Cardiovascular Disease
Smoking is a leading cause of cardiovascular disease — heart attacks, strokes, and peripheral artery disease. The mechanisms are well understood: combustion products damage blood vessel linings, promote plaque buildup, increase blood clotting, and reduce oxygen delivery.
| Cardiovascular Factor | Smoking | Vaping | Difference |
|---|---|---|---|
| Carbon monoxide binding | CO binds to 4-15% of hemoglobin | No CO production (no combustion) | Eliminated |
| Endothelial damage | Severe — combustion products directly damage vessel lining | Mild — nicotine causes vasoconstriction; PG/VG aerosol less damaging | Significantly reduced |
| Heart rate increase | +10-20 bpm during and after smoking | +5-10 bpm (nicotine effect only) | ~50% less |
| Blood pressure | Chronic elevation | Transient elevation during use | Significantly reduced |
| Platelet activation (clotting) | Increased — raises heart attack risk | Mild increase from nicotine | Significantly reduced |
Evidence Confidence: Cardiovascular
HIGH Smoking causes cardiovascular disease — established causation.
MODERATE Vaping reduces cardiovascular risk factors — CO is eliminated, endothelial damage is reduced. However, nicotine itself has cardiovascular effects, and the long-term impact of chronic vaping on heart health is not yet fully characterized.
Key study: The VapeScan study (covered in our heart health analysis) found that dual users (vaping + smoking) showed less cardiovascular improvement than exclusive vapers — suggesting that complete switching, not dual use, is necessary for meaningful risk reduction.
3. Respiratory Health
This is where the vaping-vs-smoking comparison gets most nuanced. Smoking destroys lungs through tar deposition, chronic inflammation, and cilia paralysis. Vaping doesn't produce tar, but the aerosol is not inert.
| Respiratory Factor | Smoking | Vaping | Difference |
|---|---|---|---|
| Tar deposition in lungs | Heavy — accumulates over years | None — no combustion | 100% eliminated |
| COPD risk | Leading cause — 80% of COPD cases | No confirmed cases caused solely by vaping | Risk appears minimal |
| Lung cancer risk | Leading cause — 80-90% of cases | No confirmed cases from vaping alone | Risk appears minimal |
| Airway inflammation markers | Severely elevated | 16% of smoker levels (2024 study) | ~84% reduction |
| Cough and phlegm production | Chronic smoker's cough | Mild cough in some users; may improve when switching from smoking | Significantly reduced |
| Bronchial irritation | Chronic | Acute irritation in some users (PG sensitivity) | Reduced but not eliminated |
Evidence Confidence: Respiratory
HIGH Smoking causes COPD, emphysema, and lung cancer.
MODERATE Vaping significantly reduces respiratory risk — no tar, fewer inflammation markers. However, chronic inhalation of PG/VG aerosol and flavoring compounds may cause airway irritation in some individuals.
LOW Long-term effects of decades of vaping on lung function — insufficient data (vaping has not existed long enough).
For a deeper dive on EVALI, COPD, and popcorn lung myth-busting, see our lung health research guide.
4. Reproductive Health
Smoking during pregnancy is one of the most preventable causes of infant mortality and low birth weight. The evidence on vaping during pregnancy is less clear.
| Reproductive Factor | Smoking | Vaping |
|---|---|---|
| Low birth weight | Well-established risk (20-30% increased risk) | Nicotine itself restricts fetal blood flow; full risk profile unknown |
| Preterm delivery | Increased risk (27% higher) | Data limited; nicotine exposure is the primary concern |
| Stillbirth | Increased risk | Insufficient data |
| Sudden Infant Death Syndrome (SIDS) | Increased risk from secondhand smoke | Nicotine exposure risk; secondhand vape less harmful than smoke |
| Fetal brain development | Nicotine disrupts development | Nicotine is present in most e-liquids — same risk from nicotine |
Important: The CDC, FDA, and all major medical organizations advise against vaping during pregnancy. While vaping eliminates combustion-related risks (CO, tar), nicotine itself restricts fetal blood flow and may impair brain development. If you are pregnant and trying to quit smoking, consult your doctor about the safest cessation method. See our mental health and vaping guide for cessation strategies.
5. Immune Function
Smoking suppresses immune function, making smokers more susceptible to respiratory infections, slower wound healing, and reduced vaccine effectiveness. Vaping's impact on immunity is an active area of research.
| Immune Factor | Smoking | Vaping |
|---|---|---|
| Respiratory infection susceptibility | Significantly increased (impaired cilia, damaged macrophages) | Moderate increase (PG aerosol may impair macrophage function) |
| Wound healing | Slowed (nicotine + CO reduce blood flow) | Mildly slowed (nicotine vasoconstriction) |
| Vaccine effectiveness | Reduced immune response to vaccines | Insufficient data — nicotine may affect response |
| Lung macrophage function | Severely impaired | Moderately impaired (flavoring compounds, particularly cinnamaldehyde) |
Evidence Confidence: Immune Function
HIGH Smoking suppresses immune function.
LOW Vaping's long-term immune effects — limited data, active research area.
6. Mental Health and Nicotine Dependence
Both smoking and vaping deliver nicotine, which is addictive. The mental health comparison is complex — nicotine has both cognitive benefits (attention, memory) and risks (dependence, withdrawal, anxiety).
| Mental Health Factor | Smoking | Vaping |
|---|---|---|
| Nicotine addiction | Highly addictive | Highly addictive (salt nic may be more rapidly absorbed) |
| Depression/anxiety association | Strong bidirectional link | Strong bidirectional link (nicotine is the driver) |
| Withdrawal symptoms | Severe (irritability, cravings, anxiety) | Similar severity (nicotine-driven) |
| Cessation and mental health improvement | Quitting = antidepressant-level improvement (BMJ 2024) | Switching from smoking to vaping shows intermediate improvement |
| Ritual/behavioral addiction | Strong (hand-to-mouth, breaks, social) | Strong (and potentially more frequent — devices are always available) |
Key finding: A BMJ study (2024) found that quitting smoking produces antidepressant-level improvements in mental health. Exclusive vaping (having quit smoking) shows intermediate improvement. Dual use (both smoking and vaping) shows the worst mental health outcomes — worse than either smoking or vaping alone. For the full analysis, see our vaping and mental health research guide.
The PHE 95% Finding: What It Actually Means
The "95% safer" figure comes from a 2015 expert review commissioned by Public Health England. It's the most cited statistic in the vaping-vs-smoking debate — and the most misunderstood.
How the Number Was Derived
The PHE review used a multi-criteria decision analysis (MCDA) model. An international panel of experts scored both products on 12 harm domains:
- Product attributes (toxicity, nicotine content, combustion products)
- Health effects (morbidity, mortality, lung disease, cardiovascular disease)
- Social factors (secondhand exposure, accident risk)
Each domain was weighted and scored. The final composite score placed vaping at approximately 5% of the total harm of smoking — hence the "95% less harmful" finding.
What the 95% Does NOT Mean
The 95% is a relative risk estimate, not an absolute safety claim. It means: if smoking has a harm score of 100, vaping scores approximately 5. It does NOT mean:
- That vaping is 95% safe
- That vaping is safe for non-smokers
- That all vape products are equally safe (the PHE review was based on regulated products, not illicit disposables)
- That long-term effects are fully known
Who Endorses the Finding
- Public Health England (now OHID): Original 2015 review, reaffirmed in 2018, 2022, and 2024 updates
- Royal College of Physicians: Endorsed in their 2016 report "Nicotine without Smoke"
- UK National Health Service (NHS): Cites the 95% figure in official smoking cessation guidance
- American Cancer Society: Acknowledges vaping is less harmful than smoking but has not adopted the 95% figure
- U.S. FDA: Recognizes the potential for reduced harm but uses case-by-case PMTA authorization rather than a blanket figure
What Vaping Is NOT Safe For
Evidence-based honesty matters. Here's where vaping carries real risk:
- Non-smokers: If you don't smoke, don't vape. Nicotine is addictive, and the long-term effects of inhaling PG/VG and flavorings are unknown.
- Pregnant women: Nicotine restricts fetal blood flow. Vaping eliminates combustion risks but not nicotine risks. Consult your doctor.
- Adolescents: Nicotine affects adolescent brain development, particularly attention, memory, and impulse control. The CDC's NYTS data shows youth vaping has declined significantly since 2019, but risks remain for any youth who do use.
- People with respiratory conditions: PG and certain flavoring compounds can trigger bronchial irritation in sensitive individuals.
- Dual users: People who both smoke and vape have worse health outcomes than exclusive vapers or exclusive smokers who quit. Dual use does not deliver the harm reduction of complete switching.
Realistic Risk Reduction: What Switching Actually Achieves
If you're a current smoker considering vaping as an alternative, here's what the evidence says about realistic outcomes:
Scenario 1: Complete Switch (Smoker → Exclusive Vaper)
Expected harm reduction: 80-95% reduction in smoking-related disease risk. CO exposure drops to zero within 24 hours. Lung inflammation markers drop to ~16% of smoker levels within 4-12 weeks. Cardiovascular risk factors improve measurably. Mental health shows intermediate improvement (not as much as full nicotine cessation).
Caveat: This assumes you use FDA-authorized or regulated products, not illicit disposables with unknown contents.
Scenario 2: Dual Use (Smoker + Vaper)
Expected harm reduction: Minimal to none. Dual users typically do not reduce cigarette consumption enough to achieve meaningful risk reduction. The VapeScan study found dual users had cardiovascular outcomes closer to smokers than to exclusive vapers. Mental health outcomes for dual users are worse than either exclusive group.
Recommendation: If you're dual using, the priority is complete switching — not reducing cigarettes while adding vaping.
Scenario 3: Temporary Vaping → Full Cessation
Expected harm reduction: 100% (from smoking baseline). The Cochrane Review (2024) found e-cigarettes are more effective for cessation than NRT — 9-10 per 100 quit with e-cigarettes vs 6 per 100 with NRT. FDA-authorized devices like JUUL2 showed a 49.3% switching rate in clinical trials. The goal: use vaping as a bridge to becoming nicotine-free.
Scenario 4: Never Smoker → Vaper
Expected outcome: Net harm increase. Nicotine addiction, unknown long-term inhalation effects, and no offsetting benefit (no combustion harm to reduce). This is why youth vaping prevention is critical — the harm reduction case only applies to existing smokers.
The EVALI Lesson: Illicit Products vs Regulated Products
The 2019 EVALI outbreak caused 2,807 hospitalizations and 68 deaths. This was a public health crisis — but it was not caused by regulated nicotine vaping products. It was caused by illicit THC cartridges cut with vitamin E acetate, a thickening agent that is toxic when inhaled.
The EVALI lesson is not "vaping is dangerous" — it's "unregulated products are dangerous." Regulated nicotine vape products (especially FDA-authorized ones) have never been linked to EVALI. The October 2026 enforcement crackdown on illicit disposables, covered in our state bans report, is precisely about removing the unregulated products that pose the greatest risk.
What We Still Don't Know
Honesty about unknowns is essential for evidence-based decision-making. Here are the key gaps in our understanding:
- Long-term cancer risk: Vaping has existed for ~20 years. Cancer latency periods are 20-30 years. We don't yet have epidemiological data on whether decades of low-level carcinogen exposure from vape aerosol increases cancer risk.
- Chronic PG/VG inhalation: Propylene glycol is generally recognized as safe (GRAS) for ingestion. But inhalation is a different exposure route. Decades of inhaling PG/VG aerosol — the long-term effects are genuinely unknown.
- Flavoring compound accumulation: Some flavoring compounds (diacetyl, cinnamaldehyde, sucralose) have known respiratory toxicity at high concentrations. Whether chronic low-level exposure causes cumulative damage is unclear.
- Immune function over time: Vaping's effect on lung macrophages and immune response is an active research area. Short-term studies show mild impairment, but long-term data is lacking.
- Dual use health outcomes: Most studies compare exclusive vapers to exclusive smokers. Real-world data on long-term dual users is limited but suggests outcomes closer to smoking than to exclusive vaping.
The Verdict: Evidence-Based Summary
| Claim | Evidence Level | Sources |
|---|---|---|
| Vaping is less harmful than smoking | HIGH | PHE, RCP, NHS, Cochrane, CDC |
| Vaping eliminates combustion-related disease (tar, CO) | HIGH | Chemical analysis, toxicology |
| Vaping is approximately 95% less harmful than smoking | MODERATE | PHE MCDA model (expert estimate, not direct measurement) |
| Vaping helps smokers quit | HIGH | Cochrane Review 2024, JUUL2 clinical trials |
| Long-term vaping health effects are fully known | INSUFFICIENT | Insufficient longitudinal data (vaping <20 years old) |
| Vaping is safe for non-smokers | FALSE | Nicotine addiction, unknown long-term effects |
| All vape products carry the same risk | FALSE | FDA-authorized vs illicit products differ significantly; EVALI caused by illicit THC products |
Frequently Asked Questions
Is vaping safer than smoking?
Public Health England's landmark review concluded that vaping is approximately 95% less harmful than smoking combustible cigarettes. This finding is based on the absence of combustion in vaping, which eliminates tar and carbon monoxide — the two leading causes of smoking-related disease. However, "safer" does not mean "safe." Vaping still exposes users to nicotine, propylene glycol, and flavoring compounds whose long-term effects are still being studied.
Does vaping cause cancer?
No confirmed cases of cancer caused solely by vaping have been reported as of 2026. Vape aerosol contains significantly fewer carcinogens than cigarette smoke — 9 compounds listed as probably carcinogenic by IARC in vape aerosol vs 70+ in cigarette smoke. However, long-term cancer risk from low-level carcinogen exposure in vape aerosol cannot be fully ruled out because vaping has not existed long enough for epidemiological cancer studies.
How does vaping affect your lungs compared to smoking?
Smoking causes chronic obstructive pulmonary disease (COPD), emphysema, and lung cancer through tar deposition and chronic inflammation. Vaping does not produce tar and causes measurably less airway inflammation. A 2024 study found exclusive vapers had only 16% of the lung inflammation markers found in smokers. However, vaping can cause acute bronchial irritation, increased cough, and impaired mucociliary clearance in some users.
What does the PHE 95% safer figure actually mean?
Public Health England's 95% figure means that the total harm from vaping is estimated to be approximately 5% of the harm from smoking combustible tobacco. This is based on the multi-criteria decision analysis (MCDA) model developed by an international expert panel. The 95% figure is a relative risk estimate, not an absolute safety claim. It means that if smoking has a harm score of 100, vaping scores approximately 5.
Can vaping help you quit smoking?
Yes. Multiple studies, including the Cochrane Review (2024), found that nicotine e-cigarettes are more effective for smoking cessation than nicotine replacement therapy (NRT). The review found high-certainty evidence that approximately 9-10 per 100 people quit smoking using e-cigarettes versus 6 per 100 using NRT. FDA-authorized devices like JUUL2 showed a 49.3% switching rate in clinical trials.
Is secondhand vape exposure dangerous?
Secondhand vape aerosol contains far fewer toxicants than secondhand cigarette smoke. A 2024 study measured 99% reduction in PM2.5 particles in vape aerosol compared to cigarette smoke. However, secondhand vape is not risk-free — it contains nicotine, ultrafine particles, and volatile organic compounds. The long-term health effects of chronic secondhand vape exposure are not yet fully understood.
What are the long-term risks of vaping we don't know yet?
The main unknown is the effect of decades-long inhalation of propylene glycol, vegetable glycerin, and flavoring compounds. Vaping has existed for less than 20 years, which is insufficient for epidemiological studies on diseases with long latency periods like cancer or COPD. Other unknowns include: effects of chronic dual use (vaping + smoking), impact on immune function over time, and whether certain flavoring compounds accumulate in lung tissue.
Is nicotine from vaping more dangerous than nicotine from smoking?
No. Nicotine itself has similar effects regardless of delivery method. The danger from smoking comes primarily from the 7,000+ chemicals produced by combustion, not from nicotine. Nicotine is addictive and has cardiovascular effects (increased heart rate, blood pressure), but it is not a carcinogen. The key health difference between vaping and smoking is the absence of combustion products — not the nicotine.
Consumer Decision Checklist
If You're a Current Smoker Considering Vaping
- Commit to complete switching, not dual use — partial switching delivers minimal harm reduction
- Choose an FDA-authorized device (JUUL2, Vuse Pro) or a reputable refillable system — see our FDA-authorized buying guide
- Match your nicotine strength to avoid withdrawal — see our salt nic vs freebase guide
- Set a quit date for vaping too — the ultimate goal is nicotine freedom, not permanent vaping
- Avoid illicit disposables (Elf Bar, Lost Mary from unauthorized channels) — use regulated products only
- Practice battery safety — see our battery safety guide
- Talk to your doctor about a cessation plan that uses vaping as a stepping stone
If You're a Non-Smoker
- Do not start vaping — the harm reduction case does not apply to you
- Nicotine is addictive, and long-term inhalation effects are unknown
- If you're considering vaping for flavor or social reasons, the risk outweighs any benefit
Research Notice: The health comparisons in this guide are based on peer-reviewed studies and official public health positions as of October 2026. Vaping research is an active field, and findings may be updated as new data becomes available. We will update this guide when significant new evidence emerges.
FDA Regulatory Notice: As of September 2026, approximately 95 tobacco products from 11 companies have received FDA PMTA marketing authorization. Only these products are legally marketed in the United States. Check the FDA-authorized product list before purchasing.
Sources & Further Reading
- Public Health England. (2015, updated 2024). "E-cigarettes: an evidence update." McNeill A, Brose LS, Calder R, et al. — gov.uk
- Royal College of Physicians. (2016). "Nicotine without smoke: Tobacco harm reduction." — rcplondon.ac.uk
- Cochrane Review. (2024). "Electronic cigarettes for smoking cessation." Hartmann-Boyce J, et al. — cochrane.org
- National Academies of Sciences, Engineering, and Medicine. (2018). "Public Health Consequences of E-Cigarettes." — nationalacademies.org
- U.S. Centers for Disease Control and Prevention. (2026). "Smoking & Tobacco Use: Health Effects." — cdc.gov
- U.S. Food and Drug Administration. (2026). "Modified Risk Tobacco Products." — fda.gov
- NHS UK. (2026). "Using e-cigarettes to stop smoking." — nhs.uk
- BMJ. (2024). "Smoking cessation and depression/anxiety improvement." — bmj.com
- International Agency for Research on Cancer (IARC). (2024). "Monographs on the Evaluation of Carcinogenic Risks to Humans." — iarc.who.int
- U.S. Surgeon General. (2016, updated 2024). "E-Cigarette Use Among Youth and Young Adults." — cdc.gov
- National Institute on Drug Abuse. (2025). "Nicotine and the Adolescent Brain." — nida.nih.gov
- Truth Initiative. (2025). "Vaping vs Smoking: What the Science Says." — truthinitiative.org
Make an Evidence-Based Switch
If you're ready to switch from smoking to regulated vaping, start with our FDA-authorized device guide.
Explore Safe Options